Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3037 (LINC03037, also known as TP53LC17) is a member of the lincRNA class—autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes[4][7]. These RNAs can play roles in gene expression regulation and chromatin remodeling, but for LINC03037 specifically, there is no direct evidence for its function, disease involvement, or role as a drug target or biomarker at this time[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3037 (LINC03037).